Roger Sawhney

Insider Reports History

Location
C/O Omega Therapeutics, Inc., 20 Acorn Park D, Cambridge, MA
Signature
/s/ Tuan Nguyen as attorney-in-fact for Roger Sawhney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roger Sawhney:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. Chief Financial Officer Common Stock 2.94K $23.5K $8.00 Aug 3, 2021 Direct
Arbutus Biopharma Corp Director Stock Option (Right to Buy) 158K Aug 4, 2025 Direct
Omega Therapeutics, Inc. Chief Financial Officer Option (Right to Buy) 60K Mar 9, 2022 Direct
ACTUATE THERAPEUTICS, INC. Director Non-Qualified Stock Options 30K Aug 12, 2024 Direct
ACTUATE THERAPEUTICS, INC. Director Stock Options 15K May 22, 2025 Direct
ALIMERA SCIENCES INC Director Stock Option (Right to Buy) 2.25K Feb 25, 2023 Direct

Insider Reports Filed by Roger Sawhney

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABUS Arbutus Biopharma Corp Aug 4, 2025 1 $0 4 Aug 6, 2025 Director
ABUS Arbutus Biopharma Corp Aug 4, 2025 0 $0 3 Aug 6, 2025 Director
ACTU ACTUATE THERAPEUTICS, INC. May 22, 2025 1 $0 4 May 23, 2025 Director
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 1 $0 4 Aug 14, 2024 Director
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 0 $0 3 Aug 14, 2024 Director
ALIM ALIMERA SCIENCES INC Feb 25, 2023 1 $0 4 Mar 1, 2023 Director
ALIM ALIMERA SCIENCES INC Feb 25, 2023 0 $0 3 Mar 1, 2023 Director
OMGA Omega Therapeutics, Inc. Mar 9, 2022 1 $0 4 Mar 11, 2022 Chief Financial Officer
OMGA Omega Therapeutics, Inc. Aug 3, 2021 1 $50K 4 Aug 3, 2021 Chief Financial Officer
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Chief Financial Officer